×
About 745 results

ALLMedicine™ Glucose Tolerance Testing Center

Research & Reviews  252 results

Impact of earlier gestational diabetes screening for pregnant people with obesity on ma...
https://doi.org/10.1515/jpm-2021-0581
Journal of Perinatal Medicine; Hillier TA, Pedula KL et. al.

May 10th, 2022 - Gestational diabetes (GDM) screening at 24-28 weeks' gestation reduces risk of adverse maternal and perinatal outcomes. While experts recommend first-trimester screening for high-risk patients, including those with obesity, data supporting this re...

Oral Glucose Tolerance Test Measures of First-Phase Insulin Response and their Predicti...
https://doi.org/10.1210/clinem/dgac285
The Journal of Clinical Endocrinology and Metabolism; Baidal DA, Warnock M et. al.

May 8th, 2022 - Decreased first-phase insulin response (FPIR) during intravenous glucose tolerance testing (IVGTT) is an early indicator of β-cell dysfunction and predictor of type 1 diabetes (T1D). Assess whether oral glucose tolerance test (OGTT) measures could...

Function outperforms morphology in the assessment of muscular contribution to insulin s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977731
Diabetes & Vascular Disease Research; Wanger L, Gar C et. al.

Apr 1st, 2022 - Skeletal muscle contributes significantly to insulin sensitivity in humans. However, which non-invasive measurement best reflects this contribution remains unknown. Consequently, this paper compares morphologic and functional measurements. We cond...

Association between hepatic iron overload assessed by magnetic resonance imaging and gl...
https://doi.org/10.1016/j.numecd.2022.02.013
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Naeem M, Schipf S et. al.

Mar 15th, 2022 - While there is evidence that iron overload disorders are associated with type 2 diabetes, the relationship between hepatic iron overload and prediabetes remains unclear. We aimed to investigate the association between hepatic iron overload, as ass...

The impact of high-intensity interval training on postprandial glucose and insulin: A s...
https://doi.org/10.1016/j.diabres.2022.109815
Diabetes Research and Clinical Practice; Khalafi M, Ravasi AA et. al.

Mar 11th, 2022 - We performed a systematic review and meta-analysis to investigate the effects of high-intensity interval training (HIIT) on postprandial glucose (PPG) and insulin (PPI) versus non-exercise control and moderate-intensity continuous training (MICT) ...

see more →

Drugs  8 results see all →

Clinicaltrials.gov  16 results

Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans
https://clinicaltrials.gov/ct2/show/NCT05058690

Mar 8th, 2022 - This multicentre prospective study will evaluate the ability of the FatHealth technology to correctly identify individuals with pre-diabetes and diabetes, validating the technology against the current gold-standard diagnostic method, oral glucose ...

Texting for Diabetes
https://clinicaltrials.gov/ct2/show/NCT03025984

Nov 3rd, 2021 - As a part of routine care, pregnant women without known diabetes undergo screening and testing for gestational diabetes either with a two-hour glucose tolerance testing or a one-hour glucose challenge test followed by a three-hour glucose toleranc...

Glucose Homeostasis in Pseudohypoparathyroidism
https://clinicaltrials.gov/ct2/show/NCT03761290

May 27th, 2021 - Pseudohypoparathyroidism type 1A (PHP1A) is a rare, genetic disorder caused by impaired stimulatory G-protein signaling due to heterozygous mutations in the gene, GNAS. The most severe form of the disease, PHP1A occurs when a GNAS mutation is inhe...

Exploring Nutritype Signature of Type 2 Diabetes Risks in Women Post-Gestational Diabetes Mellitus
https://clinicaltrials.gov/ct2/show/NCT04190199

Dec 9th, 2019 - Women with a history of gestational diabetes mellitus (GDM) or post-GDM are at high risk of developing type 2 diabetes (T2DM). This is important in the present context because T2DM has reached epidemic proportions. In Malaysia, the prevalence of T...

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine
https://clinicaltrials.gov/ct2/show/NCT00867126

Nov 26th, 2018 - OBJECTIVES: Primary To describe changes in markers of insulin resistance, including serum adiponectin levels, standard glucose tolerance testing, and fasting serum glucose and insulin levels, in patients with previously treated metastatic adenocar...

see more →

News  22 results

More Sleep, Fewer Calories Consumed
https://www.medpagetoday.com/neurology/sleepdisorders/97048

Feb 7th, 2022 - More sleep was linked with fewer calories consumed, a single-center randomized clinical trial showed. Compared with controls, young adults who were overweight and habitually slept less than 6.5 hours a night slept an extra 1.2 hours on average aft...

In gestational diabetes, early postpartum glucose testing is a winner
https://www.mdedge.com/internalmedicine/article/218148/obstetrics/gestational-diabetes-early-postpartum-glucose-testing?channel=39313
Kari Oakes

Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.

Teplizumab delays onset of type 1 diabetes
https://www.mdedge.com/pediatrics/article/202556/diabetes/teplizumab-delays-onset-type-1-diabetes
Bianca Nogrady

Jun 9th, 2019 - The monoclonal antibody teplizumab may delay the onset of type 1 diabetes in individuals at high risk, according to research presented at the annual scientific sessions of the American Diabetes Association. In this study, 76 first-degree relatives.

Safe and Cheap Metformin Prevents Type 2 Diabetes Over 15 Years
https://www.medscape.com/viewarticle/911202

Apr 2nd, 2019 - Metformin continues to reduce the likelihood of developing type 2 diabetes among those at high risk for it over 15 years, particularly among those with higher baseline glycemia and women with a history of gestational diabetes mellitus (GDM). Findi...

Safe and Cheap Metformin Prevents Type 2 Diabetes Over 15 Years
https://www.staging.medscape.com/viewarticle/911202

Apr 2nd, 2019 - Metformin continues to reduce the likelihood of developing type 2 diabetes among those at high risk for it over 15 years, particularly among those with higher baseline glycemia and women with a history of gestational diabetes mellitus (GDM). Findi...

see more →